Gabon, Douglas M.
HRN: 25-48-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/16/2025
04/22/2025
IV
500 Mg
Q8
Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes